<DOC>
	<DOC>NCT01452412</DOC>
	<brief_summary>Kidney disease is a common medical condition. Individuals with kidney disease develop a build-up of acid in their blood. This acid can affect their muscles, bones, glucose metabolism and kidneys. The investigators will test alkali treatment, to treat acid build-up, in a randomized placebo-controlled clinical trial to evaluate effects on muscles, bones, glucose metabolism and kidney.</brief_summary>
	<brief_title>Alkali Therapy in Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<criteria>Estimate GFR &lt;= 45 and &gt;15 ml/min/1.73m2 Age &gt;18 Previous chronic treatment with alkali within the last 3 months (including sodium bicarbonate, calcium carbonate or baking soda) bicarbonate level &lt;20 or &gt;25 mEq/L New York Heart Association Class III or IV heart failure Systolic blood pressure &gt;180 mmHg Initiation of ESRD treatment planned within 6 months Kidney transplantation Treatment with immunosuppressives within the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Alkali</keyword>
	<keyword>Sodium bicarbonate</keyword>
	<keyword>Kidney disease</keyword>
	<keyword>Acidosis</keyword>
</DOC>